Compare ATLO & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATLO | RGC |
|---|---|---|
| Founded | 1903 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.2M | 9.8B |
| IPO Year | N/A | 2021 |
| Metric | ATLO | RGC |
|---|---|---|
| Price | $23.02 | $33.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.9K | ★ 362.2K |
| Earning Date | 01-23-2026 | 10-24-2025 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 82.57 | N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $60,568,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.82 | ★ N/A |
| Revenue Growth | ★ 18.60 | N/A |
| 52 Week Low | $16.04 | $0.09 |
| 52 Week High | $24.36 | $83.60 |
| Indicator | ATLO | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 77.24 |
| Support Level | $22.62 | $20.70 |
| Resistance Level | $23.42 | $25.50 |
| Average True Range (ATR) | 0.45 | 3.55 |
| MACD | -0.12 | 0.91 |
| Stochastic Oscillator | 26.25 | 89.57 |
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.